• 107026+ Medical Conferences
  • 232 Specialties
  • 21582 Organizers
  • 131570 Speakers
  • 151 Countries
  • 4040 Cities
35675+
CME Conference Registrations Sold
Home  >  Conferences  >  19th Biennial Urologic Cancer Course
CME : 17.75
Conference Brochure

19th Biennial Urologic Cancer Course is organized by Harvard Medical School (HMS) and will be held during Oct 11 - 13, 2018 at Four Seasons Hotel Boston, Boston, Massachusetts, United States of America.

The target audience for this medical event is Primary Care Physicians, Specialty Physicians, Physician Assistants, Nurses, Nurse Practitioners. This course may also be of interest to physicians who practice in Family Medicine, Geriatrics, Hospice and Palliative Medicine, Internal Medicine, Oncology and Hematology, Pathology, Radiology, Urology and Radiation Oncology. This CME Conference has been approved for a maximum of 17.75 AMA PRA Category 1 Credits.

This Conference educates community-based and academic clinicians on best practices for multi-disciplinary management of genitourinary (GU) cancers. The course is designed to provide the audience with information regarding current and new treatment and management recommendations of GU cancers and help them develop strategies to integrate this knowledge into their practices. This course is a live course with didactic lectures, panel discussions, Q&A sessions, and case review and feedback using an audience response and social media systems.

Learning Objectives :

Upon completion of this course, participants will be able to:
• Apply Level 1 evidence on the use of novel anti-androgen and/or chemotherapy to manage men with newly diagnosed metastatic and high-risk non-metastatic prostate cancer
• Apply Level 1 evidence on the use of active surveillance for men with newly diagnosed low or intermediate risk prostate cancer
• Apply level 1 evidence on the optimal approach and sequencing of new agents including immunotherapy in the management of advanced renal and bladder cancers
• Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced testicular cancer
• Apply Level 1 evidence on the management of superficial and invasive bladder cancer
• Appropriately use multiparametric MRI, fusion biopsy and novel markers in men at risk for prostate cancer
• Apply novel minimally invasive treatments for GU malignancies including prostate, bladder and kidney cancer.

Additional details will be posted as soon as they are available.

Registration Desk

Contact No. (617) 384-8600
Email
cemarketing@hms.harvard.edu

Conference Fee Details

Conference Fee : USD $650.00
Early Fee : NA
Early Fee Last date : NA

  • Drive Walk Transit Bicycle

Venue Address

Four Seasons Hotel Boston
200 Boylston Street
Boston, Massachusetts, United States Of America

Official Hotel

Four Seasons Hotel Boston,

200 Boylston St,

Boston, Massachusetts, United States of America 02116,

+1 617-338-4400

Plan Your Travel

 
 
 
 

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Four Seasons Boston
0.03 miles from venue
Revere Hotel Boston Common
0.1 miles from venue
Close

Session Details

Session Topic Start Time End Time Location Description Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee
-->

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news